TriaGen Wealth Management’s Walmart Inc WMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Hold
3,472
0.1% 145
2026
Q1
$432K Hold
3,472
0.12% 127
2025
Q4
$387K Sell
3,472
-18,819
-84% -$2.02M 0.1% 135
2025
Q3
$2.3M Sell
22,291
-1,142
-5% -$114K 0.6% 52
2025
Q2
$2.29M Buy
23,433
+19,841
+552% +$1.89M 0.69% 40
2025
Q1
$315K Buy
3,592
+114
+3% +$10.7K 0.11% 135
2024
Q4
$314K Sell
3,478
-872
-20% -$75.7K 0.11% 136
2024
Q3
$351K Hold
4,350
0.12% 130
2024
Q2
$295K Hold
4,350
0.11% 138
2024
Q1
$262K Hold
4,350
0.11% 143
2023
Q4
$229K Buy
4,350
+81
+2% +$4.29K 0.11% 144
2023
Q3
$228K Hold
4,269
0.12% 137
2023
Q2
$224K Hold
4,269
0.1% 156
2023
Q1
$210K Buy
+4,269
New +$203K 0.11% 153
2022
Q2
Sell
-4,221
Closed -$210K 197
2022
Q1
$210K Hold
4,221
0.11% 160
2021
Q4
$204K Buy
+4,221
New +$202K 0.1% 178
2021
Q3
Sell
-4,221
Closed -$201K 199
2021
Q2
$201K Buy
+4,221
New +$197K 0.1% 183

Other funds holding WMT

TriaGen Wealth Management's WMT Position: Q2 2026 in Review

TriaGen Wealth Management held its Walmart Inc (WMT) position steady in Q2 2026 at 3,472 shares worth $393K. The position accounts for 0.1% of the portfolio, ranked #145.

TriaGen Wealth Management first reported a position in WMT in Q2 2021 and has held it in 17 quarters since. The position peaked at $2.3M in Q3 2025. 4,416 funds tracked by Wall St. Rank hold WMT as of Q2 2026.

  • TriaGen Wealth Management held 3,472 shares of Walmart Inc worth $393K as of Q2 2026.
  • TriaGen Wealth Management left its Walmart Inc share count unchanged in Q2 2026.
  • Walmart Inc made up 0.1% of TriaGen Wealth Management's portfolio in Q2 2026, its #145 holding.
  • TriaGen Wealth Management first reported a position in Walmart Inc in Q2 2021 and has held it in 17 quarters since.
  • TriaGen Wealth Management's Walmart Inc position peaked at $2.3M in Q3 2025.
  • 4,416 funds tracked by Wall St. Rank held Walmart Inc as of Q2 2026.

Based on TriaGen Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.